1. Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes
- Author
-
Ethel Codner D, Elena Carrasco P, Sylvia Flores, Scherezade Momin, Bárbara Angel B, and Francisco Pérez-Bravo
- Subjects
Male ,Adolescent ,Genotype ,Insulin Antibodies ,Endocrinology, Diabetes and Metabolism ,Programmed Cell Death 1 Receptor ,Polymerase Chain Reaction ,Gene dosage ,Endocrinology ,Antigen ,Antigens, CD ,Reference Values ,Internal Medicine ,Humans ,Cytotoxic T cell ,Medicine ,CTLA-4 Antigen ,Allele ,Child ,Autoantibodies ,Polymorphism, Genetic ,business.industry ,Haplotype ,DNA ,General Medicine ,Molecular biology ,Immunoglobulin Fc Fragments ,Diabetes Mellitus, Type 1 ,Genetic epidemiology ,Immunology ,Female ,Restriction fragment length polymorphism ,Apoptosis Regulatory Proteins ,business ,Polymorphism, Restriction Fragment Length - Abstract
To explore the contribution of the PD-1 gene polymorphisms involved in T1D as well as the relationship between the PD-1/CTLA-4 genes and soluble CTLA-4 concentrations.261 incident cases of T1D and 280 healthy children less 15 years old were included in this study. Haplotypes for polymorphisms of the PD-1 and CTLA-4 genes were determined by PCR and RFLP methods. Screening for soluble CTLA-4 was done using an ELISA assay. Statistical analysis was performed using the online SHESIS package.Our results show that sCTLA-4 levels were higher in T1D than in controls (2.99+/-1.7 ng/ml versus 1.43+/-0.31 ng/ml, p0.001). The allele dosage of CTLA-4 on PD-1 haplotypes, showing a significant modified effect of G carriers over AA genotype on the sCTLA-4 concentrations (5.48+/-2.09 ng/ml versus 3.27+/-1.30 ng/ml, p0.03 in T-C haplotype) and (1.92+/-0.79 ng/ml versus 3.41+/-1.10 ng/ml, p0.02 in C-T haplotype).Consistent with the higher serum sCTLA-4 levels observed in other autoimmune diseases, our results suggest that sCTLA-4 is elevated in T1D. Our data suggest a possible gene dosage effect of "G"CTLA-4 carriers on sCTLA-4 over the possible protective or susceptible effect conferred by PD-1 haplotypes.
- Published
- 2009
- Full Text
- View/download PDF